16 November 2026
The study reports the results of the proof-of-concept trial conducted in collaboration with the Anti-Doping Laboratory Qatar and RigiTech. Blood, urine and Dried Blood Spot (DBS) samples were transported by quadcopter drone and by car over distances of 5 km and 20 km, with a third set of samples remaining untransported as a control.
Researchers assessed a broad range of anti-doping relevant biomarkers, including Athlete Biological Passport haematological parameters, the urinary steroid profile, routine clinical chemistry markers and the metabolomic profile of DBS samples.
The study found no significant differences between car and drone transport for the key haematological, steroidal and routine clinical chemistry biomarkers examined. Across the 664 metabolites detected in DBS samples, 92.3% were classified as equivalent between drone and car transport at 5 km and 88.0% at 20 km. No metabolite showed opposing directional changes between the two transport modes.
“The publication of these results is an important milestone for the ITA’s Integrity in Flight project because it provides peer-reviewed scientific evidence that under our experimental conditions, drone transport can be operated while preserving the analytical integrity of anti-doping samples ” said Benjamin Cohen, ITA Director General. “This gives us a stronger scientific basis to continue exploring where drone technology could provide a practical additional solution for anti-doping, particularly when speed, distance or geography create transport challenges.”
The authors conclude that, under the conditions tested, drone transport was a feasible alternative to ground transport and had the potential to provide faster delivery while maintaining analytical integrity. They also note that further validation over longer distances and across a wider range of operational conditions is needed before broader implementation.
ITA experts Dr Mark Stuart OBE, Head of the ITA Academy and a sports pharmacist with extensive experience in anti-doping and medical operations at major sporting events, and Dr Neil Robinson, ITA Head of Science & Medical and an expert in anti-doping sciences, are among the study’s authors. Both contributed to the study design and scientific discussions underpinning the research.
The Qatar trial represents the first phase of the ITA’s broader Integrity in Flight project. Building on those findings, the ITA has since extended its research significantly, most recently through a 1,000 km ultra-long-distance test flight in Nenana, Alaska, in August 2026. That study is examining whether blood parameters relevant to the Athlete Biological Passport remain stable during much longer drone journeys and under a very different operational environment.
Together, the Qatar and Alaska studies reflect a progressive research approach: first establishing feasibility over short distances, then testing the concept over far greater distances and in more demanding conditions.
The aim of Integrity in Flight is not to replace established transport arrangements, but to assess whether drones could become an additional option in specific situations, including major sporting events, congested urban environments, mountainous regions or remote locations.
The open-access study, “Impact of Drone Versus Car Transport on Anti-Doping Sample Integrity Over Short Distances: A Proof-Of-Concept Study,” is published in Drug Testing and Analysis and is available via DOI: 10.1002/dta.70151.